Upgrade to SI Premium - Free Trial

ACHFF (ACHFF)

0.35 +0.02 (6.06%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Arch Biopartners Featured in American Diabetes Association Thought Leadership Series at the 2026 Scientific Sessions in New Orleans June 4, 2026 7:41 AM - Globe NewsWire Arch Biopartners announces Royal Columbian Hospital has dosed its first patient in its Phase II cardiac surgery-associated AKI trial May 22, 2026 6:50 AM - Globe NewsWire Royal Columbian Hospital begins patient recruitment in Arch Biopartners’ Phase II trial of LSALT peptide targeting CS-AKI April 30, 2026 7:00 AM - Globe NewsWire Arch Biopartners raises $600,000 in private placement offering April 2, 2026 5:45 AM - StreetInsider Arch Biopartners Closes Non-Brokered Private Placement April 2, 2026 5:45 AM - Globe NewsWire Arch Biopartners arranges $600,000 private placement at $0.60 per share March 30, 2026 6:03 AM - StreetInsider Arch Biopartners Arranges Non-Brokered Private Placement March 30, 2026 6:03 AM - Globe NewsWire Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II Cardiac Surgery-Associated AKI Trial March 24, 2026 9:13 AM - Globe NewsWire Full Article List